Saved in:
| Main Authors: | Adyasa, Zoya Marie, Putri, Nurhayati, Herlambang, Afri, Nedra, Wan, Pradipta, Ariel |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Online Access: | https://doi.org/10.5281/zenodo.15428886 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Clinical Utility of Prenatal cfDNA Screening for Sex Chromosome Aneuploidies: A Single Center Experience
by: Ying Lin, et al.
Published: (2026)
by: Ying Lin, et al.
Published: (2026)
Prenatal Screening Via cfDNA – Paired‐End Sequencing Utilizing Fragment Size Information Reduces the Screen Positive Rate for X Chromosome Aneuploidies
by: Susan Hancock, et al.
Published: (2026)
by: Susan Hancock, et al.
Published: (2026)
Detection of fetal cfDNA in maternal blood
by: Klaus Rieneck, et al.
Published: (2025)
by: Klaus Rieneck, et al.
Published: (2025)
Correspondence on “Current Controversy in Prenatal Diagnosis: The Use of cfDNA to Screen for Monogenic Conditions in Low Risk Populations Is Ready for Clinical Use”
by: Julia Wynn, et al.
Published: (2024)
by: Julia Wynn, et al.
Published: (2024)
Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
by: Marta Victoria Lorenzo‐Sánchez, et al.
Published: (2025)
by: Marta Victoria Lorenzo‐Sánchez, et al.
Published: (2025)
Persistent Uninterpretable or Failed Prenatal Cell‐Free DNA Screening Indicates a High‐Risk Pregnancy and is Associated With Biological Factors Interfering With cfDNA‐Analysis: A Prospective Cohort Study
by: L. Lannoo, et al.
Published: (2025)
by: L. Lannoo, et al.
Published: (2025)
Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients
by: İrem Peker Eyüboğlu, et al.
Published: (2024)
by: İrem Peker Eyüboğlu, et al.
Published: (2024)
Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non‐small cell lung cancer patients
by: Yidan Ma, et al.
Published: (2024)
by: Yidan Ma, et al.
Published: (2024)
From DNA Methylation Microarray to Digital PCR : A Stepwise Strategy for Tissue Specific cfDNA Biomarker Development
by: David H. Murray, et al.
Published: (2026)
by: David H. Murray, et al.
Published: (2026)
Interfacial cfDNA Enrichment and Amplification with On‐Chip Thermoplasmonics for Highly Sensitive Cancerous Liquid Biopsy
by: Danhua Wang, et al.
Published: (2024)
by: Danhua Wang, et al.
Published: (2024)
Immediate Postoperative cfDNA Elevation Predicts Pain After Robot‐Assisted Radical Prostatectomy
by: Noritaka Ishii, et al.
Published: (2025)
by: Noritaka Ishii, et al.
Published: (2025)
5‐Hydroxymethylcytosine Profiles of cfDNA in Urine as Diagnostic, Differential Diagnosis and Prognostic Markers for Multiple Myeloma
by: Weiwei Xie, et al.
Published: (2024)
by: Weiwei Xie, et al.
Published: (2024)
Evaluation of cfDNA fragmentation characteristics in plasma for the diagnosis of lung cancer: A prospective cohort study
by: Fudong Xu, et al.
Published: (2024)
by: Fudong Xu, et al.
Published: (2024)
Donor‐Derived Cell‐Free DNA (dd‐cfDNA) as an Early Noninvasive Biomarker of Graft Injury in Pig‐to‐Monkey Islet Xenotransplantation
by: Ji‐Jing Yan, et al.
Published: (2026)
by: Ji‐Jing Yan, et al.
Published: (2026)
Harnessing viral footprints in circulating free DNA ( cfDNA ) for early cancer detection: A focus on liquid‐biopsy‐based screening
by: Richard Donkor Amponsah, et al.
Published: (2025)
by: Richard Donkor Amponsah, et al.
Published: (2025)
Comparative Liquid Biopsy Testing for KRAS Mutations From Plasma Cell‐Free DNA ( cfDNA ) and Extracellular Vesicles in Lung Adenocarcinoma
by: Caeli J. Zahra, et al.
Published: (2026)
by: Caeli J. Zahra, et al.
Published: (2026)
LGALS3 cfDNA methylation in seminal fluid as a novel prostate cancer biomarker outperforming PSA
by: Irena Abramovic, et al.
Published: (2024)
by: Irena Abramovic, et al.
Published: (2024)
The Efficacy of Liquid Biopsy of Total cfDNA for Predicting Systemic Metastasis in Japanese Patients With Oral Squamous Cell Carcinoma
by: Masahiro Uchibori, et al.
Published: (2024)
by: Masahiro Uchibori, et al.
Published: (2024)
EP17.37: Low fetal fraction of cfDNA and obstetric complications in screening centre Gennet 2019–2022
by: M. Holub, et al.
Published: (2024)
by: M. Holub, et al.
Published: (2024)
Detection of neuron‐derived cfDNA in blood plasma: A novel screening and monitoring approach for Alzheimer's disease and other neurodegenerative conditions
by: Chad Pollard
Published: (2025)
by: Chad Pollard
Published: (2025)
Towards a People-Driven African Union: Current Obstacles and New Opportunities
by: AfriMAP
Published: (2026)
by: AfriMAP
Published: (2026)
Performance of Prenatal Cell‐Free DNA Screening for Foetal Chromosome Aneuploidies and Microdeletion/Microduplication Syndromes: A Retrospective Study of 64,482 Consecutive Cases From a Prenatal Diagnosis Centre in China
by: Feiyan Pan, et al.
Published: (2025)
by: Feiyan Pan, et al.
Published: (2025)
Modern Organization Theory and Critical Organization Theory
by: Akdila Bulanov, Afri Wandi Zahri Ramadhan, Nabila Sukma, Putri Varisya
Published: (2026)
by: Akdila Bulanov, Afri Wandi Zahri Ramadhan, Nabila Sukma, Putri Varisya
Published: (2026)
Analytical and Clinical Validation of Solo‐Test Driver: A Targeted Amplicon‐Based NGS Test‐System for FFPE and cfDNA Analysis in Clinical Oncology Setting
by: Maxim Ivanov, et al.
Published: (2025)
by: Maxim Ivanov, et al.
Published: (2025)
MUTE‐Seq: An Ultrasensitive Method for Detecting Low‐Frequency Mutations in cfDNA With Engineered Advanced‐Fidelity FnCas9 (Adv. Mater. 47/2025)
by: Sunghyeok Ye, et al.
Published: (2025)
by: Sunghyeok Ye, et al.
Published: (2025)
Microkinetic Modelling of Electrochemical Oxygen Evolution Reaction on Ir(111)@N‐Graphene Surface
by: Adyasa Priyadarsini, et al.
Published: (2025)
by: Adyasa Priyadarsini, et al.
Published: (2025)
Nuchal Translucency Measurement in First Trimester Screening Ultrasound as a Marker of Abnormal Cell‐Free DNA on Non‐Invasive Prenatal Testing
Published: (2025)
Published: (2025)
Public Perspectives Around Prenatal Screening of Chromosomal Abnormalities: A Focus Group Study Comparing Metropolitan and Rural/Regional Areas in Australia
by: Amber Salisbury, et al.
Published: (2025)
by: Amber Salisbury, et al.
Published: (2025)
Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes
by: Ivonne Bedei, et al.
Published: (2025)
by: Ivonne Bedei, et al.
Published: (2025)
Can cell‐free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic biomarker among surgically treated Stage I−III a nonsmall cell lung cancer (NSCLC)? A pilot study
by: Jyoutishman Saikia, et al.
Published: (2024)
by: Jyoutishman Saikia, et al.
Published: (2024)
Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma‐based collection of 77 patients with locally advanced unresectable esophageal cancer
by: Anouchka Modesto, et al.
Published: (2025)
by: Anouchka Modesto, et al.
Published: (2025)
Chromosomal Microarray Analysis and Karyotype Analysis for Prenatal Diagnosis of Fetuses With Abnormal Ultrasound Soft Markers
by: Lina Liu, et al.
Published: (2025)
by: Lina Liu, et al.
Published: (2025)
Analysis of Prenatal Diagnosis and Pregnancy Decisions of 767 Singleton Pregnancies With Positive Prenatal Cell‐Free DNA Screening Results in Southwest China
by: Yun Chen, et al.
Published: (2025)
by: Yun Chen, et al.
Published: (2025)
DNA Mimic Foldamer Recognition of a Chromosomal Protein
by: Deepak Deepak, et al.
Published: (2025)
by: Deepak Deepak, et al.
Published: (2025)
Analyse et modélisation des paramètres d’exploitation des stocks du Bivalve Ruditapes decussatus des côtes Tunisiennes.
by: Zamouri-Langar, Nedra
Published: (2010)
by: Zamouri-Langar, Nedra
Published: (2010)
Unit Time/Cost Study of the Cataloging Unit, Technical Services Division, Tucson Public Library.
by: Kayner, Nedra L.
Published: (1978)
by: Kayner, Nedra L.
Published: (1978)
Frequency and Distribution of Incidental Chromosomal Abnormalities Detected by Peripheral Blood Karyotyping: A Retrospective Study
by: Yaqin Zhang, et al.
Published: (2026)
by: Yaqin Zhang, et al.
Published: (2026)
Chromosomal Structural Abnormality Diagnosis by Homologous Similarity
by: Li, Juren, et al.
Published: (2024)
by: Li, Juren, et al.
Published: (2024)
Improving the Performance of Prenatal Cell‐Free DNA Screening Through Size‐Selective Fetal DNA Enrichment in a Cohort of 71,986 General and High‐Risk Pregnancies
by: Liang Hu, et al.
Published: (2025)
by: Liang Hu, et al.
Published: (2025)
Evaluating Chromosomal Mosaicism in Prenatal Diagnosis: The Complementary Roles of Chromosomal Microarray Analysis and Karyotyping
by: Chenxia Xu, et al.
Published: (2025)
by: Chenxia Xu, et al.
Published: (2025)
Similar Items
-
Clinical Utility of Prenatal cfDNA Screening for Sex Chromosome Aneuploidies: A Single Center Experience
by: Ying Lin, et al.
Published: (2026) -
Prenatal Screening Via cfDNA – Paired‐End Sequencing Utilizing Fragment Size Information Reduces the Screen Positive Rate for X Chromosome Aneuploidies
by: Susan Hancock, et al.
Published: (2026) -
Detection of fetal cfDNA in maternal blood
by: Klaus Rieneck, et al.
Published: (2025) -
Correspondence on “Current Controversy in Prenatal Diagnosis: The Use of cfDNA to Screen for Monogenic Conditions in Low Risk Populations Is Ready for Clinical Use”
by: Julia Wynn, et al.
Published: (2024) -
Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
by: Marta Victoria Lorenzo‐Sánchez, et al.
Published: (2025)